Large-scale testing (Phase 3)Study completedNCT00556296
What this trial is testing
Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD
Who this might be right for
Attention Deficit Hyperactivity Disorder
New River Pharmaceuticals 297